By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Afexa Life Sciences Inc. 

Corporate Office
9604 20th Avenue
Edmonton  Alberta  T6N 1G1  Canada
Phone: 780-432-0022 Fax: 780-432-7772


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Evidera Announces Release FDA Draft Guidance On Use Of The "EXACT" To Measure Symptoms Of COPD Exacerbations 1/14/2014 10:53:53 AM
Valeant Pharmaceuticals International (VRX) Announces the Completion of the Privatization of Afexa Life Sciences Inc. 12/13/2011 9:01:01 AM
Valeant Pharmaceuticals International (VRX) Announces Take-Up of Additional Afexa Life Sciences Inc. Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization 10/28/2011 10:47:58 AM
Valeant Pharmaceuticals International (VRX) Announces Results of Friendly Offer for Afexa Life Sciences Inc. 10/18/2011 6:01:38 AM
Valeant Pharmaceuticals International (VRX) Announces That Afexa Life Sciences Inc. Supports and Recommends Valeant's Increased Offer and Agrees to Certain Amendments to Support Agreement 10/3/2011 5:55:45 AM
Valeant Pharmaceuticals International (VRX) Trumps Paladin Labs Inc. (CC:PLB) for Afexa Life Sciences Inc. With $78 Million Bid 9/26/2011 8:04:39 AM
Valeant Pharmaceuticals International (VRX) Nabs Afexa Life Sciences Inc. for $76 Million Cash; Beats Paladin Labs Inc. (CC:PLB) to the Punch 8/30/2011 7:15:00 AM
Afexa Life Sciences Inc. Asks Shareholders to Reject Hostile Paladin Labs Inc. (CC:PLB) Bid 8/24/2011 6:46:02 AM
Paladin Labs Inc. (CC:PLB) Makes Takeover Bid for Afexa Life Sciences Inc. Worth $56.7 Million 8/10/2011 8:08:16 AM
Afexa Life Sciences Inc. Announces CEO Succession Process 6/24/2011 7:59:44 AM
12
//-->